pharma-technology
(4)
Zach Taft
Zach Taft is the CEO of IgniteData, a healthcare technology company whose Archer platform automates the transfer of clinical trial data straight from hospital electronic health records into pharma data-capture systems. Brought in by the founders in 2024, he has scaled the company from a handful of trial sites to a network spanning four continents and eight of the top ten U.S. cancer centers. Before IgniteData he helped drive the $1.1B acquisition of M*Modal by 3M, served as a 3M product leader, and ran digital innovation and ventures at Memorial Sloan Kettering, where he co-founded the Clinical Research Innovation Consortium. His obsession: cutting the weeks of manual data re-typing out of clinical trials so treatments reach patients faster.
Mural Health
Mural Health is a Berwyn, Pennsylvania-based clinical research technology company whose Mural Link platform is billed as the industry's first participant management system. It combines patient payments, travel and rideshare booking, two-way messaging, and real-time experience feedback into one participant-first tool aimed at helping people enroll in and stay in clinical trials while easing the administrative burden on research sites and sponsors. Founded in 2022 by Sam Whitaker - the inventor of the original ClinCard payment technology at Greenphire - the company positions itself against legacy prepaid-card systems, notably by eliminating the inactivity fees that quietly drain participant balances.
BlinkRx
BlinkRx is the enterprise platform of New York-based Blink Health, founded by brothers Geoffrey and Matthew Chaiken. Billed as a 'pharma-to-patient cloud,' it lets pharmaceutical manufacturers run the entire prescription journey - pricing, prior authorization, copay assistance, fulfillment, free home delivery, and adherence support - on a single system. Its consumer side offers cash-pay discounts and an online pharmacy. The company says it supports millions of patients across all 50 states and has raised hundreds of millions in venture funding.
Geoffrey Chaiken
Geoffrey Chaiken is the co-founder and CEO of BlinkRx (Blink Health), a New York-based digital health company rebuilding how prescription drugs get priced, paid for, and delivered. The son and grandson of physicians, he gave up a career in medicine to attack what he calls the real bottleneck in healthcare - not discovering new cures, but getting existing ones into patients' hands at a fair price. With his younger brother Matthew, he has raised more than half a billion dollars to digitize both the patient front end and the pharmaceutical industry's back end, partnering with drug makers and tens of thousands of pharmacies to strip middlemen out of the medication supply chain.